MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Anxiety"

  • MDS Virtual Congress 2020

    Anxiety in Parkinson’s disease is associated with changes in the brain fear circuit

    G. Carey, R. Lopes, R. Viard, N. Betrouni, G. Kuchcinski, Q. Devignes, L. Defebvre, A. Leentjens, K. Dujardin (Lille, France)

    Objective: The aim of this study was to identify the anatomical and functional changes related to anxiety, especially in the “fear circuit”, by comparing PD…
  • MDS Virtual Congress 2020

    Endophenotyping adult-onset isolated cervical dystonia: Does period of onset of mood disorder matter?

    I. Ndukwe, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: We aim to characterize clinical and demographic features pertaining to the time of onset of mood disorder in CD patients. Background: Mood disorder frequently…
  • MDS Virtual Congress 2020

    Neuroimaging of anxiety in Parkinson’s disease: a systematic review

    G. Carey, M. Görmezoğlu, K. Dujardin, A. Leentjens (Maastricht, Netherlands)

    Objective: The aim of this systematic review was 1) to identify the brain regions involved in anxiety in Parkinson's disease (PD) based on neuroimaging studies,…
  • MDS Virtual Congress 2020

    Fatigue in patients with focal and segmental dystonia

    S. Tomic, Z. Popovic, I. Mandic, T. Gilman Kuric, R. Perkovic, H. Bradvica (Osijek, Croatia)

    Objective: To determine relation of fatigue to depression, anxyety and sleep disorder in patients with focal and segmental dystonia. Background: Dystonia is movement disorder characterised…
  • MDS Virtual Congress 2020

    Improving Diagnosis and Treatment of Anxiety in Parkinson’s Disease: IDATA-PD Study Update

    N. Dissanayaka, G. Byrne, L. Mitchell, J. O'Sullivan, A. Padmassini, E. White, J. Yang, E. Forbes, K. Thangavelu, T. Au, A. Lehn, R. Adam, N. Pachana (Brisbane, Australia)

    Objective: 1. To develop an inventory to assess Parkinson’s disease (PD) specific anxiety for person centred psychotherapy interventions. 2. To develop manualised cognitive behaviour therapy…
  • MDS Virtual Congress 2020

    Weeding Through the Haze: A Survey on Cannabis Use Among People with Parkinson’s Disease

    M. Feeney, B. Kluger, A. Stoessl, D. Bega, S. Gilbert, A. Hosang, E. Ogren, K. Schroeder, C. Evers, J. Beck (New York, NY, USA)

    Objective: To identify themes in cannabis use among people with Parkinson’s disease to inform medical recommendations and the design of future clinical trials. Background: Parkinson’s…
  • MDS Virtual Congress 2020

    Video-to-Home Cognitive-Behavioral Therapy for Veterans with Depression and Parkinson’s Disease: A Randomized Controlled Trial

    R. Dobkin, S. Mann, K. Rodriguez, L. St. Hill, R. Miller, A. King, M. Gara, A. Interian (Piscataway, NJ, USA)

    Objective: For the nearly 100,000 veterans with Parkinson’s disease (PD) receiving Veterans Affairs (VA) health care, depression is prevalent, yet often undiagnosed or undertreated. This…
  • MDS Virtual Congress 2020

    Carers of People Living with Parkinson’s Disease, the 2019 European Realities

    H. Rossinot, P.M Martin, P. Odin, K.R Chaudhuri, C. Billoet, S. Lindwall (Nancy, France)

    Objective: PD as a chronic disease interferes with the life of non professional relatives caring for the patient (carers). The aim of this survey is…
  • MDS Virtual Congress 2020

    Fear of progression in Parkinson’s disease: Preliminary results of a pilot cross-sectional study

    A. Folkerts, J. Saliger, J. Nielsen, H. Karbe, M. Goosses, V. Vida, C. Trenkwalder, A. Kruse, H. Oelsner, G. Ebersbach, E. Kalbe (Cologne, Germany)

    Objective: To examine the prevalence of fear of progression (FoP) in Parkinson's disease (PD) patients, and to analyze which sociodemographic, clinical and neuropsychological factors are…
  • MDS Virtual Congress 2020

    Differential burden of comorbidities for Huntington’s Disease, Parkinson’s Disease and the general population for patients and care partners in the US

    A. Exuzides, J. Matos, B. Ricker, D. Bega (South San Francisco, CA, USA)

    Objective: Describe the comorbidity burden for patients (pt) and care partners (cp) of Huntington’s Disease (HD), Parkinson’s Disease (PD) and the general population (GP) Background:…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley